SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,499.17 -455.59
( -0.58%)

Global Indices

Nasdaq

54,056.75 150.65
(0.28%)

Dow Jones

7,778.11 47.15
(0.61%)

Hang Seng

65,597.55 -85.71
(-0.13%)

Nikkei 225

10,909.12 41.23
(0.38%)

Forex

USD-INR

95.20 0.13
(0.14%)

EUR-INR

109.83 0.08
(0.08%)

GBP-INR

128.13 0.14
(0.11%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4616629

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

41.48

12407.62

EPS(TTM)

Face Value()

Div & Yield %

6.6

0.33

Back

Pearl Global Industries consolidated net profit rises 48.20% in the June 2026 quarter

Aug 06,2026

Net profit of Pearl Global Industries rose 48.20% to Rs 100.51 crore in the quarter ended June 2026 as against Rs 67.82 crore during the previous quarter ended June 2025. Sales rose 24.46% to Rs 1528.26 crore in the quarter ended June 2026 as against Rs 1227.92 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1528.26	1227.92	24
OPM %	10.72	9.16	-
PBDT	147.96	96.37	54
PBT	122.30	76.65	60
NP	100.51	67.82	48

78,499.17 -455.59 ( -0.58%)

54,056.75 150.65 (0.28%)

7,778.11 47.15 (0.61%)

65,597.55 -85.71 (-0.13%)

10,909.12 41.23 (0.38%)

95.20 0.13 (0.14%)

109.83 0.08 (0.08%)

128.13 0.14 (0.11%)

0.60 0.00 (-0.12%)